Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $29.7800 (-3.15%) ($29.7500 - $30.8830) on Tue. Oct. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.02% (three month average) | RSI | 72 | Latest Price | $29.7800(-3.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 4.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(48%) IWM(47%) IWC(44%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.01% in a week (0% probabilities). VIXM(-31%) UUP(-14%) VXX(-13%) EDOC(-5%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.01% (StdDev 2.02%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $30.55(-2.52%) | 10 Day Moving Average | $29.9(-0.4%) | 20 Day Moving Average | $28.65(3.94%) | To recent high | -4.2% | To recent low | 15.7% | Market Cap | $4.07b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |